Hinlun Chen
Co-founder · President & COO
Hong Kong, China & Asia-Pacific
Based in Hong Kong
Seed round
We're raising our seed round.
Auratwin launches to the public in August 2026, and our first clinical trials with the Chinese Academy of Sciences follow. This round pays for the launch, the trials, and taking our three devices through certification.
Write to us New pitch deck ready Aug 3
Who to talk to
One founder replies directly, depending on where you invest from.
Stephen Okita
Co-founder · CEO & CTO
Europe & North America
Based in San Francisco
What's already behind us
28 UK pharmacy partnerships from our prior venture
$134k UK government funding awarded
$300k angel investment, Hong Kong
~$400k in resources from the Founders Factory Healthcare accelerator
If you're new to Auracare
This page assumes you've seen the site. If you haven't, start with these.
Auratwin The consumer product: a wellness companion in your messages. Launches August 2026.Auracare, the clinical product Decision support inside the consultation, fed by our own devices. In development.How the technology works The patient state, the reasoning loop and the safety gates, explained in full.The live ontology 532,000 clinical concepts you can explore today.
Questions investors ask us
How much are you raising?
We share the target and terms directly rather than posting them here. Write to the founder for your region and we’ll walk you through the deck.
What’s live today, and what isn’t?
The ontology is live and explorable: 532,000 clinical concepts. Auratwin launches to the public in August 2026. Auracare, the clinical product, is in development and targeted for May 2027.
Who’s already backing you?
A $300k angel investment from Hong Kong, around $400k in resources from the Founders Factory Healthcare accelerator, and $134k in UK government funding. Our prior venture also built 28 UK pharmacy partnerships.
How do you handle regulation?
Auratwin ships as a general-wellness product under the FD&C Act §520(o)(1)(B) exclusion, so it never diagnoses or treats. Auracare is clinical decision support; its regulatory pathway is under active review, and its first trials run with the Chinese Academy of Sciences.
Why does clinical work start in China?
Our partnership with the Chinese Academy of Sciences gives us clinical trials and the resources to run them. One deployment can feed several regulatory dossiers at once, so we sequence markets by how far an approval travels.
Can I get a data room?
Yes. Email the founder for your region and they’ll set you up.